Beth Marsh will lead commercialization for Neurotech, which gained FDA approval for its eye disease therapy. Neurotech in May ...

1, Megan Khang, .82%. 2 (tie), Hannah Green, Jeongeun Lee5, Yealimi Noh, Haeran Ryu and Rio Takeda, .81%. 7, 4 tied with .80%. 1, Saki Baba, 1.62. 2, Jeeno Thitikul, 1.65. 3, Sophia Popv, 1.67. 4 (tie ...

Retro-style first-person survival horror game Labyrinth Of The Demon King will launch for PlayStation 5, Xbox Series, PlayStation 4, Xbox One, Switch, and PC via Steam on May 13, publisher Top Hat ...

Thousands crowded San Francisco's Japantown on Sunday for the 58th annual Cherry Blossom Festival. Kiyomi Takeda, who's part of the festival's non-profit arm, said there was plenty for people to ...

Akie Iwai shot an 8-under 64 playing alongside her twin sister Saturday for a share of the third-round lead in the JM Eagle ...

From joint ventures to licensing deals, biotechnology is emerging as a strategic bridge between China and Japan.

Belief BioMed (BBM) and Takeda China have announced China’s National Medical Products Administration's (NMPA) approval for ...

Belo, a member of PRWeek’s 2024 Health Influencer list, joined Takeda in 2021 as VP and global head of external communications. The company promoted him to SVP and head of global corporate brand and ...

"We are excited to see mezagitamab progress into Phase 3 trials, marking a significant step for Takeda and our n-CoDeR platform," said Martin Welschof, Chief Executive Officer of BioInvent.

"We are excited to see mezagitamab progress into Phase 3 trials, marking a significant step for Takeda and our n-CoDeR platform," said Martin Welschof, Chief Executive Officer of BioInvent.

"We are excited to see mezagitamab progress into Phase 3 trials, marking a significant step for Takeda and our n-CoDeR platform," said Martin Welschof, Chief Executive Officer of BioInvent. "This ...